Dietary wolfberry ameliorates retinal structure abnormalities in db/db mice at the early stage of diabetes

Experimental Biology and Medicine

Volumn 236, Issue 9, 2011, Pages 1051-1063

  Tang, Ling ^a   Zhang, Yunong ^a   Jiang, Yu ^a   Willard, Lloyd ^a   Ortiz, Edlin ^a   Wark, Logan ^a   Medeiros, Denis ^a   Lin, Dingbo ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

AMPK; Diabetic retinopathy; ER stress; Reactive oxygen species; Wolfberry; Zeaxanthin

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 6; ADENOSINE PHOSPHATE; BIOLOGICAL MARKER; CAROTENOID; CASPASE 12; GLUCOSE; IMMUNOGLOBULIN; MANGANESE SUPEROXIDE DISMUTASE; PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; SUPEROXIDE DISMUTASE; THIOREDOXIN; TRANSCRIPTION FACTOR FKHRL1; XANTHOPHYLL; ZEAXANTHIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CELL LINE; CELL LYSATE; CONTROLLED STUDY; DIETARY INTAKE; ENDOPLASMIC RETICULUM STRESS; FEEDING; GANGLION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LYCIUM; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PHOTORECEPTOR; PIGMENT EPITHELIUM; PROTEIN BINDING; RETINA DISEASE; UPREGULATION; WESTERN BLOTTING;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BLOOD GLUCOSE; BURKITT LYMPHOMA; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; DIET; ENDOPLASMIC RETICULUM; GENE KNOCKDOWN TECHNIQUES; HUMANS; INSULIN; LYCIUM; MALE; MICE; MICE, INBRED C57BL; PHYTOTHERAPY; REACTIVE OXYGEN SPECIES; RETINA;

MUS;

EID: 80052502391     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2011.010400     Document Type: Article

References (51)

1. Busik JV, Mohr S, Grant MB. Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators. Diabetes 2008;57:1952-65.
2. Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2006;29:1963-72.
3. Sanz P. AMP-activated protein kinase: structure and regulation. Curr Protein Pept Sci 2008;9:478-92.
4. Zhang BB, Zhou G, Li C. AMPK: an emerging drug target for diabetes and the metabolic syndrome. Cell Metab 2009;9: 407-16.
5. Kukidome D, Nishikawa T, Sonoda K, Imoto K, Fujisawa K, Yano M, Motoshima H, Taguchi T, Matsumura T, Araki E. Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells. Diabetes 2006;55:120-7.
6. Leverve XM, Guigas B, Detaille D, Batandier C, Koceir EA, Chauvin C, Fontaine E, Wiernsperger NF. Mitochondrial metabolism and type-2 diabetes: a specific target of metformin. Diabetes Metab 2003;29:S88-94.
7. Rutter GA, Leclerc I. The AMP-regulated kinase family: enigmatic targets for diabetes therapy. Mol Cell Endocrinol 2009;297:41-9.
8. Kim I, Xu W, Reed JC. Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat Rev Drug Discov 2008;7:1013-30.
9. Malhotra JD, Kaufman RJ. Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword? Antioxid Redox Signal 2007;9:2277-93.
10. Oshitari T, Hata N, Yamamoto S. Endoplasmic reticulum stress and diabetic retinopathy. Vasc Health Risk Manag 2008;4:115-22.
11. Potterat O. Goji (Lycium barbarum and L. chinense): phytochemistry, pharmacology and safety in the perspective of traditional uses and recent popularity. Planta Med 2010;76:7-19.
12. Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 2007;8:519-29.
13. Görlach A, Klappa P, Kietzmann T. The endoplasmic reticulum: folding, calcium homeostasis, signaling, and redox control. Antioxid Redox Signal 2006;8:1391-418.
14. Faitova J, Krekac D, Hrstka R, Vojtesek B. Endoplasmic reticulum stress and apoptosis. Cell Mol Biol Lett 2006;11:488-505.
15. Inbaraj BS, Lu H, Hung CF, Wu WB, Lin CL, Chen BH. Determination of carotenoids and their esters in fruits of Lycium barbarum Linnaeus by HPLC-DAD-APCI-MS. J Pharm Biomed Anal 2008;47:812-8.
16. Inbaraj BS, Lu H, Kao TH, Chen BH. Simultaneous determination of phenolic acids and flavonoids in Lycium barbarum Linnaeus by HPLC-DAD-ESI-MS. J Pharm Biomed Anal 2010;51:549-56.
17. Chang RC, So KF. Use of anti-aging herbal medicine, Lycium barbarum, against aging-associated diseases. What do we know so far? Cell Mol Neurobiol 2008;28:643-52.
18. Ho YS, So KF, Chang RC. Anti-aging herbal medicine - how and why can they be used in aging-associated neurodegenerative diseases? Ageing Res Rev 2010;9:354-62.
19. Yemm EW, Willis AJ. The estimation of carbohydrates in plant extracts by anthrone. Biochem J 1954;57:508-14.
20. Peri C, Pompei C. An assay of different phenolic fractions in wines. Am J Enol Vitic 1971;22:55-8.
21. Lin D, Takemoto DJ. Oxidative activation of protein kinase Cgamma through the C1 domain. Effects on gap junctions. J Biol Chem 2005;280:13682-93.
22. Yevseyenkov VV, Das S, Lin D, Willard L, Davidson H, Sitaramayya A, Giblin FJ, Dang L, Takemoto DJ. Loss of protein kinase Cgamma in knockout mice and increased retinal sensitivity to hyperbaric oxygen. Arch Ophthalmol 2009;127:500-6.
23. Arnal E, Miranda M, Johnsen-Soriano S, Alvarez-Nölting R, Díiaz-Llopis M, Araiz J, Cervera E, Bosch-Morell F, Romero FJ. Beneficial effect of docosahexanoic acid and lutein on retinal structural, metabolic, and functional abnormalities in diabetic rats. Curr Eye Res 2009;34:928-38.
24. Béby F, Housset M, Fossat N, Le Greneur C, Flamant F, Godement P, Lamonerie T. Otx2 gene deletion in adult mouse retina induces rapid RPE dystrophy and slow photoreceptor degeneration. PLoS One 2010;5:e11673
25. Jones DP. Redox sensing: orthogonal control in cell cycle and apoptosis signalling. J Intern Med 2010;268:432-48.
26. Nishikawa T, Araki E. Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications. Antioxid Redox Signal 2007;9:343-53.
27. Kim A, Joseph S, Khan A, Epstein CJ, Sobel R, Huang TT. Enhanced expression of mitochondrial superoxide dismutase leads to prolonged in vivo cell cycle progression and up-regulation of mitochondrial thioredoxin. Free Radic Biol Med 2010;48:1501-12.
28. Tremblay ML, Giguére V. Phosphatases at the heart of FoxO metabolic control. Cell Metab 2008;7:101-3.
29. Maiese K, Chong ZZ, Hou J, Shang YC. The 'O' class: crafting clinical care with FoxO transcription factors. Adv Exp Med Biol 2009;665:242-60.
30. Kops GJ, Dansen TB, Polderman PE, Saarloos I, Wirtz KW, Coffer PJ, Huang TT, Bos JL, Medema RH, Burgering BM. Forkhead transcription factor FOXO3α protects quiescent cells from oxidative stress. Nature 2002;419:316-21.
31. Li XN, Song J, Zhang L, LeMaire SA, Hou X, Zhang C, Coselli JS, Chen L, Wang XL, Zhang Y, Shen YH. Activation of the AMPK-FOXO3 pathway reduces fatty acid-induced increase in intracellular reactive oxygen species by upregulating thioredoxin. Diabetes 2009;58:2246-57.
32. Li B, Vachali P, Bernstein PS. Human ocular carotenoid-binding proteins. Photochem Photobiol Sci 2010;9:1418-25.
33. During A, Doraiswamy S, Harrison EH. Xanthophylls are preferentially taken up compared with beta-carotene by retinal cells via a SRBI-dependent mechanism. J Lipid Res 2008;49:1715-24.
34. Midena E, Segato T, Radin S, di Giorgio G, Meneghini F, Piermarocchi S, Belloni AS. Studies on the retina of the diabetic db/db mouse. I. Endothelial cell-pericyte ratio. Ophthalmic Res 1989;21:106-11.
35. Tadayoni R, Paques M, Gaudric A, Vicaut E. Erythrocyte and leukocyte dynamics in the retinal capillaries of diabetic mice. Exp Eye Res 2003;77:497-504.
36. Clements RS Jr Robison WG Jr, Cohen MP. Anti-glycated albumin therapy ameliorates early retinal microvascular pathology in db/db mice. J Diabetes Complications 1998;12:28-33.
37. Barile GR, Pachydaki SI, Tari SR, Lee SE, Donmoyer CM, Ma W, Rong LL, Buciarelli LG, Wendt T, Hörig H, Hudson BI, Qu W, Weinberg AD, Yan SF, Schmidt AM. The RAGE axis in early diabetic retinopathy. Invest Ophthalmol Vis Sci 2005;46:2916-24.
38. Cheung AK, Fung MK, Lo AC, Lam TT, So KF, Chung SS, Chung SK. Aldose reductase deficiency prevents diabetes-induced blood-retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/ db mice. Diabetes 2005;54:3119-25.
39. Li J, Wang JJ, Chen D, Mott R, Yu Q, Ma JX, Zhang SX. Systemic administration of HMG-CoA reductase inhibitor protects the blood- retinal barrier and ameliorates retinal inflammation in type 2 diabetes. Exp Eye Res 2009;89:71-8.
40. Li J, Wang JJ, Yu Q, Chen K, Mahadev K, Zhang SX. Inhibition of reactive oxygen species by Lovastatin downregulates vascular endothelial growth factor expression and ameliorates blood-retinal barrier breakdown in db/db mice: role of NADPH oxidase 4. Diabetes 2010;59:1528-38.
41. Sohn EJ, Kim YS, Kim CS, Lee YM, Kim JS. KIOM-79 prevents apoptotic cell death and AGEs accumulation in retinas of diabetic db/db mice. J Ethnopharmacol 2009;121:171-4.
42. Yeung CM, Lo AC, Cheung AK, Chung SS, Wong D, Chung SK. More severe type 2 diabetes-associated ischemic stroke injury is alleviated in aldose reductase-deficient mice. J Neurosci Res 2010;88:2026-34.
43. Sasaki M, Ozawa Y, Kurihara T, Kubota S, Yuki K, Noda K, Kobayashi S, Ishida S, Tsubota K. Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes. Diabetologia 2010;53:971-9.
44. Bernstein PS, Balashov NA, Tsong ED, Rando RR. Retinal tubulin binds macular carotenoids. Invest Ophthalmol Vis Sci 1997;38:167-75.
45. Crabtree DV, Ojima I, Geng X, Adler AJ. Tubulins in the primate retina: evidence that xanthophylls may be endogenous ligands for the paclitaxel-binding site. Bioorg Med Chem 2001;9:1967-76.
46. Bhosale AJL, Frederick J, Southwick K, Thulin CD, Bernstein PS. Identification and characterization of a pi isoform of glutathione S-transferase as a zeaxanthin-binding protein in the macula of the human eyej. J Biol Chem 2004;279:49447-54.
47. Kowluru RA, Menon B, Gierhart DL. Beneficial effect of zeaxanthin on retinal metabolic abnormalities in diabetic rats. Invest Ophthalmol Vis Sci 2008;49:1645-51.
48. Hou X, Song J, Li XN, Zhang L, Wang X, Chen L, Shen YH. Metformin reduces intracellular reactive oxygen species levels by upregulating expression of the antioxidant thioredoxin via the AMPK-FOXO3 pathway. Biochem Biophys Res Commun 2010;396:199-205.
49. Katoh M, Katoh M. Human FOX gene family (Review). Int J Oncol 2004;25:1495-500.
50. Kukidome D, Nishikawa T, Sonoda K, Imoto K, Fujisawa K, Yano M, Motoshima H, Taguchi T, Matsumura T, Araki E. Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells. Diabetes 2006;55:120-7.
51. Li J, Wang JJ, Yu Q, Wang M, Zhang SX. Endoplasmic reticulum stress is implicated in retinal inflammation and diabetic retinopathy. FEBS Lett 2009;583:1521-7